HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyperbaric oxygen for idiopathic sudden hearing loss: is the routine application helpful?

AbstractCONCLUSION:
We recommend the routine application of hyperbaric oxygen (HBO) in conjunction with intravenous steroid (IVS) for all patients with idiopathic sudden sensorineural hearing loss (ISSNHL). For best results, this therapy must be started within 14 days.
OBJECTIVE:
To investigate the necessity of routine application of HBO therapy for ISSNHL.
METHODS:
This was a retrospective cohort study. A total of 300 patients (300 diseased ears) were divided into 3 groups according to the therapy received: IVS (group A), HBO (group B), or IVS + HBO (group C). Patients in each treatment group were subdivided into subgroups according to the time of therapy initiation. The outcomes of their hearing recovery were classified into three recovery grades: good, fair, and poor.
RESULTS:
The proportion of patients responding to therapy and those with complete recovery was the highest in the combined treatment group, 84% and 58%, respectively, regardless of the initial hearing levels. In all the groups, mean gains of cases in whom therapy was started in the first 2 weeks were significantly higher (p < 0.05) and hypercholesterolemia (>240 mg/dl) caused significantly worse responses (p < 0.05).
AuthorsLuigi Capuano, Matteo Cavaliere, Giuseppe Parente, Alberto Damiano, Gabriella Pezzuti, Dante Lopardo, Maurizio Iemma
JournalActa oto-laryngologica (Acta Otolaryngol) Vol. 135 Issue 7 Pg. 692-7 (Jul 2015) ISSN: 1651-2251 [Electronic] England
PMID25813083 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Methylprednisolone
Topics
  • Administration, Intravenous
  • Adult
  • Aged
  • Anti-Inflammatory Agents (administration & dosage)
  • Audiometry
  • Female
  • Hearing Loss, Sensorineural (complications, therapy)
  • Hearing Loss, Sudden (complications, therapy)
  • Humans
  • Hyperbaric Oxygenation
  • Hypercholesterolemia (complications)
  • Male
  • Methylprednisolone (administration & dosage)
  • Middle Aged
  • Recovery of Function
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: